CN118512567A - 一种用于治疗失眠的中药组合物 - Google Patents
一种用于治疗失眠的中药组合物 Download PDFInfo
- Publication number
- CN118512567A CN118512567A CN202410746172.7A CN202410746172A CN118512567A CN 118512567 A CN118512567 A CN 118512567A CN 202410746172 A CN202410746172 A CN 202410746172A CN 118512567 A CN118512567 A CN 118512567A
- Authority
- CN
- China
- Prior art keywords
- parts
- traditional chinese
- chinese medicine
- medicine composition
- treating insomnia
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 111
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 title claims abstract description 91
- 239000003814 drug Substances 0.000 title claims abstract description 91
- 206010022437 insomnia Diseases 0.000 title claims abstract description 91
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 35
- 238000002791 soaking Methods 0.000 claims abstract description 33
- 239000000843 powder Substances 0.000 claims abstract description 27
- 239000002994 raw material Substances 0.000 claims abstract description 26
- 238000002360 preparation method Methods 0.000 claims abstract description 25
- 240000001008 Dimocarpus longan Species 0.000 claims abstract description 19
- 235000000235 Euphoria longan Nutrition 0.000 claims abstract description 19
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims abstract description 18
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 17
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 17
- 235000008434 ginseng Nutrition 0.000 claims abstract description 17
- 239000008187 granular material Substances 0.000 claims abstract description 15
- 239000000706 filtrate Substances 0.000 claims abstract description 11
- 238000001914 filtration Methods 0.000 claims abstract description 11
- 238000002156 mixing Methods 0.000 claims abstract description 11
- 238000001694 spray drying Methods 0.000 claims abstract description 11
- 238000005303 weighing Methods 0.000 claims abstract description 11
- 239000003826 tablet Substances 0.000 claims abstract description 8
- 239000002775 capsule Substances 0.000 claims abstract description 6
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims description 19
- 244000303040 Glycyrrhiza glabra Species 0.000 claims description 19
- 235000017443 Hedysarum boreale Nutrition 0.000 claims description 17
- 235000007858 Hedysarum occidentale Nutrition 0.000 claims description 17
- 241000234435 Lilium Species 0.000 claims description 17
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 claims description 17
- 235000017166 Bambusa arundinacea Nutrition 0.000 claims description 16
- 235000017491 Bambusa tulda Nutrition 0.000 claims description 16
- 240000004371 Panax ginseng Species 0.000 claims description 16
- 235000015334 Phyllostachys viridis Nutrition 0.000 claims description 16
- 235000006886 Zingiber officinale Nutrition 0.000 claims description 16
- 240000008866 Ziziphus nummularia Species 0.000 claims description 16
- 239000011425 bamboo Substances 0.000 claims description 16
- 235000008397 ginger Nutrition 0.000 claims description 16
- 241000213006 Angelica dahurica Species 0.000 claims description 15
- 244000037364 Cinnamomum aromaticum Species 0.000 claims description 15
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 claims description 15
- 239000000463 material Substances 0.000 claims description 15
- 235000006484 Paeonia officinalis Nutrition 0.000 claims description 14
- 244000197580 Poria cocos Species 0.000 claims description 14
- 235000008599 Poria cocos Nutrition 0.000 claims description 14
- 235000006508 Nelumbo nucifera Nutrition 0.000 claims description 13
- 235000006510 Nelumbo pentapetala Nutrition 0.000 claims description 13
- 241000724115 Ziziphus lotus Species 0.000 claims description 13
- 210000000988 bone and bone Anatomy 0.000 claims description 13
- 244000001632 Acorus gramineus Species 0.000 claims description 11
- 235000013073 Acorus gramineus Nutrition 0.000 claims description 11
- 241000208966 Polygala Species 0.000 claims description 9
- 238000000034 method Methods 0.000 claims description 8
- 244000273928 Zingiber officinale Species 0.000 claims description 4
- 241001080798 Polygala tenuifolia Species 0.000 claims description 3
- 239000006187 pill Substances 0.000 claims description 2
- 240000002948 Ophiopogon intermedius Species 0.000 claims 3
- 244000170916 Paeonia officinalis Species 0.000 claims 3
- 244000082204 Phyllostachys viridis Species 0.000 claims 3
- 235000013402 health food Nutrition 0.000 claims 1
- 208000024891 symptom Diseases 0.000 abstract description 10
- 206010067484 Adverse reaction Diseases 0.000 abstract description 6
- 230000006838 adverse reaction Effects 0.000 abstract description 6
- 229940126680 traditional chinese medicines Drugs 0.000 abstract description 4
- 210000000582 semen Anatomy 0.000 abstract description 3
- 241000208340 Araliaceae Species 0.000 abstract 1
- 230000008376 long-term health Effects 0.000 abstract 1
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 39
- 239000008280 blood Substances 0.000 description 28
- 210000004369 blood Anatomy 0.000 description 28
- 210000002216 heart Anatomy 0.000 description 20
- 244000248557 Ophiopogon japonicus Species 0.000 description 14
- 241001330002 Bambuseae Species 0.000 description 13
- 210000000952 spleen Anatomy 0.000 description 13
- 241000234314 Zingiber Species 0.000 description 12
- 230000000052 comparative effect Effects 0.000 description 12
- 210000002784 stomach Anatomy 0.000 description 12
- 241001106477 Paeoniaceae Species 0.000 description 11
- 229940079593 drug Drugs 0.000 description 11
- 230000002936 tranquilizing effect Effects 0.000 description 11
- 210000001835 viscera Anatomy 0.000 description 10
- 230000007812 deficiency Effects 0.000 description 9
- 230000001105 regulatory effect Effects 0.000 description 9
- 206010033557 Palpitations Diseases 0.000 description 8
- 241000700159 Rattus Species 0.000 description 8
- 210000004185 liver Anatomy 0.000 description 6
- 210000004072 lung Anatomy 0.000 description 6
- 210000005036 nerve Anatomy 0.000 description 6
- 238000011160 research Methods 0.000 description 6
- 208000001431 Psychomotor Agitation Diseases 0.000 description 5
- 206010038743 Restlessness Diseases 0.000 description 5
- 230000000144 pharmacologic effect Effects 0.000 description 5
- 230000003860 sleep quality Effects 0.000 description 5
- 230000004622 sleep time Effects 0.000 description 5
- 244000269722 Thea sinensis Species 0.000 description 4
- 230000003213 activating effect Effects 0.000 description 4
- 230000001914 calming effect Effects 0.000 description 4
- 230000007423 decrease Effects 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 230000001939 inductive effect Effects 0.000 description 4
- 210000003734 kidney Anatomy 0.000 description 4
- WEXRUCMBJFQVBZ-UHFFFAOYSA-N pentobarbital Chemical compound CCCC(C)C1(CC)C(=O)NC(=O)NC1=O WEXRUCMBJFQVBZ-UHFFFAOYSA-N 0.000 description 4
- 239000002504 physiological saline solution Substances 0.000 description 4
- 230000007958 sleep Effects 0.000 description 4
- 206010011224 Cough Diseases 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- 229930003935 flavonoid Natural products 0.000 description 3
- 235000017173 flavonoids Nutrition 0.000 description 3
- 230000001976 improved effect Effects 0.000 description 3
- 230000007774 longterm Effects 0.000 description 3
- 229960001412 pentobarbital Drugs 0.000 description 3
- 229930182490 saponin Natural products 0.000 description 3
- 150000007949 saponins Chemical class 0.000 description 3
- 235000017709 saponins Nutrition 0.000 description 3
- 230000004799 sedative–hypnotic effect Effects 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 208000019901 Anxiety disease Diseases 0.000 description 2
- 244000025254 Cannabis sativa Species 0.000 description 2
- 206010059866 Drug resistance Diseases 0.000 description 2
- 206010013954 Dysphoria Diseases 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 244000236658 Paeonia lactiflora Species 0.000 description 2
- 235000008598 Paeonia lactiflora Nutrition 0.000 description 2
- 208000002193 Pain Diseases 0.000 description 2
- 206010034568 Peripheral coldness Diseases 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 229930013930 alkaloid Natural products 0.000 description 2
- 230000036506 anxiety Effects 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 235000019658 bitter taste Nutrition 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 230000007012 clinical effect Effects 0.000 description 2
- 230000003750 conditioning effect Effects 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 230000002354 daily effect Effects 0.000 description 2
- -1 decoction Substances 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 230000002124 endocrine Effects 0.000 description 2
- 150000002215 flavonoids Chemical class 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 235000011477 liquorice Nutrition 0.000 description 2
- 208000019423 liver disease Diseases 0.000 description 2
- 239000002858 neurotransmitter agent Substances 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 235000020098 plum wine Nutrition 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 239000013641 positive control Substances 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 208000019116 sleep disease Diseases 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 235000019605 sweet taste sensations Nutrition 0.000 description 2
- 235000019640 taste Nutrition 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 238000012795 verification Methods 0.000 description 2
- 238000010792 warming Methods 0.000 description 2
- 229940126673 western medicines Drugs 0.000 description 2
- XWSCOGPKWVNQSV-UHFFFAOYSA-N 5-bromo-2,3-dichloropyridine Chemical compound ClC1=CC(Br)=CN=C1Cl XWSCOGPKWVNQSV-UHFFFAOYSA-N 0.000 description 1
- 244000291564 Allium cepa Species 0.000 description 1
- 235000002732 Allium cepa var. cepa Nutrition 0.000 description 1
- 208000000044 Amnesia Diseases 0.000 description 1
- 208000031091 Amnestic disease Diseases 0.000 description 1
- 244000061520 Angelica archangelica Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 102000005915 GABA Receptors Human genes 0.000 description 1
- 108010005551 GABA Receptors Proteins 0.000 description 1
- 235000001287 Guettarda speciosa Nutrition 0.000 description 1
- 241000096284 Gynochthodes officinalis Species 0.000 description 1
- 206010024642 Listless Diseases 0.000 description 1
- 206010026749 Mania Diseases 0.000 description 1
- 208000019914 Mental Fatigue Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000157491 Morinda Species 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010059013 Nocturnal emission Diseases 0.000 description 1
- 229930195210 Ophiopogon Natural products 0.000 description 1
- QGMRQYFBGABWDR-UHFFFAOYSA-M Pentobarbital sodium Chemical compound [Na+].CCCC(C)C1(CC)C(=O)NC(=O)[N-]C1=O QGMRQYFBGABWDR-UHFFFAOYSA-M 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 208000010340 Sleep Deprivation Diseases 0.000 description 1
- 238000000692 Student's t-test Methods 0.000 description 1
- 206010070863 Toxicity to various agents Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 235000006545 Ziziphus mauritiana Nutrition 0.000 description 1
- 244000126002 Ziziphus vulgaris Species 0.000 description 1
- 235000008529 Ziziphus vulgaris Nutrition 0.000 description 1
- 206010000059 abdominal discomfort Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 230000006986 amnesia Effects 0.000 description 1
- 230000001430 anti-depressive effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 239000000935 antidepressant agent Substances 0.000 description 1
- 229940005513 antidepressants Drugs 0.000 description 1
- 235000019606 astringent taste Nutrition 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- AAOVKJBEBIDNHE-UHFFFAOYSA-N diazepam Chemical compound N=1CC(=O)N(C)C2=CC=C(Cl)C=C2C=1C1=CC=CC=C1 AAOVKJBEBIDNHE-UHFFFAOYSA-N 0.000 description 1
- 229960003529 diazepam Drugs 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 208000030172 endocrine system disease Diseases 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 229940125753 fibrate Drugs 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 239000003326 hypnotic agent Substances 0.000 description 1
- 230000000147 hypnotic effect Effects 0.000 description 1
- 208000034783 hypoesthesia Diseases 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 239000007928 intraperitoneal injection Substances 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 208000017971 listlessness Diseases 0.000 description 1
- 230000005976 liver dysfunction Effects 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 230000004630 mental health Effects 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 235000017524 noni Nutrition 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 229960002275 pentobarbital sodium Drugs 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 208000020016 psychiatric disease Diseases 0.000 description 1
- 235000019633 pungent taste Nutrition 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 230000004617 sleep duration Effects 0.000 description 1
- 208000020685 sleep-wake disease Diseases 0.000 description 1
- 235000019614 sour taste Nutrition 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 230000008093 supporting effect Effects 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 238000012353 t test Methods 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 229940125725 tranquilizer Drugs 0.000 description 1
- 239000003204 tranquilizing agent Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 230000002618 waking effect Effects 0.000 description 1
- 229960005111 zolpidem tartrate Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/02—Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/62—Nymphaeaceae (Water-lily family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/69—Polygalaceae (Milkwort family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/72—Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
- A61K36/725—Ziziphus, e.g. jujube
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/77—Sapindaceae (Soapberry family), e.g. lychee or soapberry
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8967—Lilium, e.g. tiger lily or Easter lily
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8968—Ophiopogon (Lilyturf)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9068—Zingiber, e.g. garden ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Polymers & Plastics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurosurgery (AREA)
- Anesthesiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明属于中药技术领域,具体涉及一种用于治疗失眠的中药组合物。本发明提供了一种用于治疗失眠的中药组合物,原料包括:炙甘草、茯苓、生姜、桂枝、酸枣仁、龙眼、莲子心、百合、人参、竹叶、龙骨、麦冬、白芍、当归、远志、石菖蒲、茯神。本发明还提供了所述中药组合物的制备方法,步骤包括:按配方称取原料粉碎后混合;将粉碎后的混合物加水浸泡;浸泡后进行煎煮;煎煮完成后进行过滤,将滤液进行浓缩,喷雾干燥,制备成颗粒剂、散剂、胶囊剂、片剂中的一种。本发明中药组合物能够有效改善失眠的症状,在临床实践中无明显不良反应,有长期保健意义。
Description
技术领域
本发明涉及中药技术领域,更具体地说,涉及一种用于治疗失眠的中药组合物。
背景技术
随着社会的快速发展和人们生活节奏的日益加快,对人体健康构成威胁的因素日益增多,其中,慢性病的发病率逐年攀升,失眠作为其中之一,其影响尤为显著。据流行病学研究显示,全球每年约有三分之一的人口面临失眠问题,且这一比例随着年龄的增长而增加。
失眠,作为一种常见的睡眠障碍,其特征是难以入睡、睡眠维持困难或早醒,导致睡眠时间和质量不满足个体的生理需求,进而影响日常生活和工作效率。失眠可以由多种原因引起,包括精神因素、疾病因素、环境因素、年龄因素、药物因素和食物因素等。长期失眠不仅会导致个体精神疲惫、注意力不集中,还可能引发一系列身心健康问题,如焦虑、抑郁、免疫力下降等。
在中医药理论中,失眠被归属于“不寐”、“目不暝”、“不得眠”等范畴。其病机总结为阴阳失调,阳不入阴。失眠的中医治疗注重整体调理,通过调和脏腑功能、平衡阴阳气血、安神定志等方法,以达到治疗失眠的目的。
目前,失眠的治疗方法主要包括药物治疗、心理治疗和生活方式调整等。其中,药物治疗因其快速、直接的疗效而得到广泛应用。然而,现有的西药治疗失眠虽然短期内能取得一定效果,但长期使用可能产生依赖性、耐药性,甚至引发一系列不良反应,如头晕、头痛、恶心等。
相比之下,中药治疗失眠具有独特的优势和潜力。中药治疗注重整体调理,通过调节人体的气血、脏腑功能,达到改善失眠的目的。同时,中药治疗副作用小、安全性高,患者依从性较好。因此,近年来,越来越多的研究者开始关注中药在失眠治疗中的应用。
然而,现有的中药治疗失眠的方案多为单味药或简单的复方制剂,其疗效和安全性仍有待提高。为了进一步提高中药治疗失眠的疗效和安全性,本发明提供了一种用于治疗失眠的中药组合物。该组合物通过精心筛选的多种中药材的配伍,结合现代药理学和临床实践经验,旨在通过调节人体的气血、脏腑功能,改善睡眠质量,缓解失眠症状。
发明内容
为了克服现有技术中的问题,本发明提供了一种用于治疗失眠的中药组合物。
第一方面,本发明提供了一种用于治疗失眠的中药组合物,采用如下的技术方案:
一种用于治疗失眠的中药组合物,包括以下重量份原料:炙甘草8-14份、茯苓12-20份、生姜10-12份、桂枝4-8份、酸枣仁10-16份、龙眼8-10份、莲子心6-12份、百合4-8份、人参10-16份、竹叶8-14份、龙骨6-10份、麦冬7-13份、白芍15-20份、当归6-8份、远志12-15份、石菖蒲15-20份、茯神14-16份。
进一步地,包括以下重量份原料:炙甘草10-12份、茯苓15-17份、生姜10-12份、桂枝5-7份、酸枣仁12-14份、龙眼8-10份、莲子心8-10份、百合5-7份、人参12-14份、竹叶10-12份、龙骨7-9份、麦冬9-11份、白芍16-18份、当归6-8份、远志12-14份、石菖蒲16-18份、茯神14-16份。
进一步地,包括以下重量份原料:炙甘草11份、茯苓16份、生姜11份、桂枝6份、酸枣仁13份、龙眼9份、莲子心9份、百合6份、人参13份、竹叶11份、龙骨8份、麦冬10份、白芍17份、当归7份、远志13份、石菖蒲17份、茯神15份。
第二方面,本发明还提供另外一种用于治疗失眠的中药组合物的制备方法,采用如下的技术方案:
一种用于治疗失眠的中药组合物的制备方法,具体包括以下制备步骤:
(1)按配方称取原料粉碎后混合;将粉碎后的混合物加水浸泡;
(2)浸泡后进行煎煮;煎煮完成后进行过滤,将滤液进行浓缩,喷雾干燥,制备成颗粒剂、散剂、胶囊剂、片剂中的一种。
进一步地,所述步骤(1)浸泡时间不少于2小时。
进一步地,所述步骤(2)中煎煮分两次,第一次加水量为混合物粉料重量的10-15倍,第二次加水量为混合物粉料重量的5-10倍,总煎煮时间为2-3小时。
第三方面,本发明还提供了用于治疗失眠的中药组合物在制备治疗失眠的药物或在制备用于辅助治疗失眠的保健食品中的应用。
第四方面,本发明还提供一种中药制剂,包括用于治疗失眠的中药组合物和药学可接受的辅料。
进一步地,所述中药制剂为颗粒剂、片剂、丸剂、汤剂、散剂、膏剂或胶囊。
综上所述,本发明具有以下有益效果:
炙甘草,具有补脾和胃、益气复脉、镇咳平喘、镇痛的功效,其味甘、性平,归心经、肺经、胃经和脾经,具有健脾益气、止咳平喘、清热解毒等功效。它能够治疗脾胃虚弱、中气下陷、气虚乏力、四肢倦怠等病症,从而缓解失眠症状。此外,炙甘草还能调和药性,增强药力,缓解药物的毒性和烈性,对于一些药物中毒的患者,也能起到治疗的效果。此外,炙甘草还能发挥调和诸药的作用,在方中起到缓和的作用。
茯苓,含有三萜酸及多糖类,在引发睡眠障碍的相关靶点-通路上起效,提高γ-氨基丁酸受体亚基水平,降低γ-亚基水平,延长戊巴比妥钠诱导下的睡眠行为,协同戊巴比妥抑制中枢神经系统,做到催眠的效果。
生姜,起到舒络活血的作用,而且其味道具有安神的效果。和胃止呕,清代名医邵兰荪有专篇论述“不寐”,认为不寐属于“胃不和则卧不安”,治疗应注意和胃安神。
桂枝,调和营卫、调整营卫巡行以和解阴阳。具有发汗解肌、助阳化气、温经通脉等功效。
酸枣仁,味酸,性平,入心、脾、肝、胆经,有宁心安神、养肝敛汗的功效,汉代《金匮要略》中用其治疗“虚烦不得眠”,元代医家朱丹溪记述酸枣仁适用于血不归脾之失眠“宜用此大补心脾,则血归脾而五脏安和,睡卧自宁”。酸枣仁为传统中药,现代对它在失眠方面的研究有大量报道,其也是临床上常用的安神药之一,它依赖于皂苷类、黄酮类、生物碱类等成分来发挥防治失眠的药理作用,通过改变人体内神经递质含量来提高睡眠质量,从而达到治疗目的。
龙眼,又称桂圆,味甘、性温、入心、脾经,具有养血安神、补益心脾之功,适用于气血不足,心悸怔忡以及健忘失眠。李时珍描述龙眼为“大补”“资益以桂圆为良”,龙眼不仅是补益良药,在现代也被作为防治失眠的食材之一,研究表明其具有抗衰老、抗肿瘤、调节免疫、平衡内分泌等药理作用。
莲子心,具有益肾固精、补脾止泻、养心安神的功效,临床上用于配伍麦冬、柏子仁、茯神等,可用于治疗虚烦、惊悸失眠;莲子心味苦,性寒,归心、肾经,最早也是作为一种食材被收录于唐代的《食性本草》中,具有清热、止血、安神等功效。现代临床研究表明其主要成分为生物碱类及黄酮类化合物,不仅能镇静、抗抑郁,还有降血糖、抑菌、抗氧化、调节血脂等药理作用。
百合,入肺、心经,有润肺止咳、清心安神之功,可用治虚烦惊悸、失眠多梦等。现代研究表明百合中的百合皂苷有一定的镇静催眠、抗抑郁、抗肿瘤作用,因此日常生活中用百合泡水代茶饮,对虚热上浮所致的失眠有一定疗效。
人参,性味甘、微苦、微温,入脾、肺、心经。它具有大补元气、补气血、安神益智等功能,对于改善血虚引起的失眠有很好的效果。
竹叶,味甘、淡,性寒,入心、肺、胆、胃经,竹叶的功效为清热除烦、止渴宁心。《神农本草经》描述其“清香载心,微苦,凉气热气俱清”“主治暑热消渴”。《本草纲目》记载其能够“去烦热,利小便,清心”。将洗干净的新鲜竹叶,放入锅内与适量清水浓煎,取温汁液当作代茶饮,每日分上下午饮服,不仅是夏天解暑的茶饮良品,还能有效治疗热病之后的睡卧难宁、心烦口渴等症状。
龙骨,具有镇惊安神,平肝潜阳,收敛固涩的功效。主治心神不宁,心悸失眠,惊痫癫狂,肝阳眩晕,对于缓解焦虑、失眠等症状有良好的效果,有助于提高睡眠质量。
麦冬,中国第一部药物学著作《神农本草经》记载的上品药物,因其块根是名贵的中草药,而成为农民种植的一种高效经济作物。麦冬也被称为“禹韭”,其来历有这样一个传说:大禹治水成功后,就命令把剩余的粮食倒进河中,河中便长出了一种草,即麦冬,人们称此草“禹余粮”。《本草衍义》《本草备要》中均记载麦冬有养阴生津、润肺清心的功效,其能养心阴,清心热,并有一定的除烦安神作用,可用于心阴虚有热所致的心烦、心悸怔忡等症。
白芍,药用根,味辛、苦;有小毒;具温阳祛湿、补体虚、健脾胃等功效。
当归,甘、辛、温,主治补血;活血;调经止痛;润燥滑肠。主血虚诸证。当归在中医临床上有补血第一药的美称,其补血养血的功效可以显著改善血虚引起的面色苍白无华、心悸、四肢麻木以及手脚冰冷等症状。这些症状的改善有助于缓解因血虚导致的失眠。
远志,具有安神益智、祛痰开窍的作用。
石菖蒲,具有开窍豁痰、醒神益智的作用。
茯神,具有镇静安神、利水渗湿的作用。
本发明配方的中药材在中医理论中均被认为具有安神、镇静、调和气血、补益脏腑等功效,适用于治疗失眠等睡眠障碍。通过现代药理学研究发现,这些中药材中含有多种有效成分,如黄酮类、皂苷类、多糖类等,这些成分能够调节神经递质、改善脑电图活动模式、促进血氧供应等,从而发挥治疗失眠的作用。
本发明的中药组合物在安全性方面具有显著优势。首先,该组合物所选用的中药材均为传统中药,经过长期的临床应用和验证,其安全性和有效性得到了广泛认可。其次,这些中药材在中医理论中均被认为具有安神、镇静、调和气血、补益脏腑等功效,且性味平和,不易产生副作用。
此外,本发明的中药组合物在配伍上充分考虑了药材之间的相互作用和药效的叠加效应,避免了可能产生的副作用和不良反应。通过现代药理学研究发现,该组合物中的多种有效成分能够协同作用,发挥更好的疗效,同时降低单一药材可能带来的不良反应。
本发明中,酸枣仁与炙甘草相伍助脾养血、补益阴津、滋养五脏。同时,人参、桂枝和酸枣仁三者复配能有效提升中药配方治疗失眠的效果。
在实际应用中,本发明的中药组合物经过严格的临床试验和验证,证实其安全有效,无明显毒副作用。患者在使用该组合物后,能够显著改善睡眠质量,缓解失眠症状,且不易产生依赖性和耐药性。
本发明中药组合物对SD大鼠的睡眠时间有明显的延长,与生理盐水组比较有显著差异。且临床药效试验也显示了本发明中药组合物疗效显著,且不良发生率低,有很好的临床效果,具有实际应用价值。
具体实施方式
下面通过具体实施方式来进一步说明本发明的技术方案。本领域技术人员应该明了,所述实施例仅仅是帮助理解本发明,不应视为对本发明的具体限制。
实施本发明的过程、条件、试剂、实验方法等,除以下专门提及的内容之外,均为本领域的普遍知识和公知常识,本发明没有特别限制内容。各实施例中未注明具体条件的实验方法,通常按照常规条件或按照制造厂商所建议的条件。
除非另有说明,本说明书中使用的全部专业术语和科学用语的含义均与本发明所属技术领域的技术人员一般理解的含义相同。但如有冲突,以包含定义的本说明书为准。
中药治疗失眠的机理主要基于中医的脏腑经络理论和气血理论。首先,中医认为失眠与心、肝、脾、肾等脏腑的功能失调有关。因此,中药治疗失眠时,会注重调整这些脏腑的功能,如通过清热泻火、滋阴补肾、疏肝解郁等方法,来改善脏腑功能,从而缓解失眠症状。此外,中医还认为气血是人体生命活动的基础,气血运行不畅会导致失眠。因此,中药治疗失眠时,会注重调整气血运行,如通过活血化瘀、补气养血等方法,来改善气血状态,从而缓解失眠症状。
本发明提出的一种用于治疗失眠的中药组合物,包括以下重量份原料:炙甘草10-12份、茯苓15-17份、生姜10-12份、桂枝5-7份、酸枣仁12-14份、龙眼8-10份、莲子心8-10份、百合5-7份、人参12-14份、竹叶10-12份、龙骨7-9份、麦冬9-11份、白芍16-18份、当归6-8份、远志12-14份、石菖蒲16-18份、茯神14-16份。
所述用于治疗失眠的中药组合物的制备方法,包括以下步骤:
(1)按配方称取原料粉碎后混合;将粉碎后的混合物加水浸泡;浸泡时间不少于2小时;
(2)浸泡后进行煎煮;第一次加水量为混合物粉料重量的10-15倍,第二次加水量为混合物粉料重量的5-10倍,总煎煮时间为2-3小时;煎煮完成后进行过滤,将滤液进行浓缩,喷雾干燥,制备成颗粒剂、散剂、胶囊剂、片剂中的一种。
下面结合具体实施例对本发明作进一步解说:
实施例1
本实施例用于治疗失眠的中药组合物,由以下重量份原料制成:炙甘草11份、茯苓16份、生姜11份、桂枝6份、酸枣仁13份、龙眼9份、莲子心9份、百合6份、人参13份、竹叶11份、龙骨8份、麦冬10份、白芍17份、当归7份、远志13份、石菖蒲17份、茯神15份。
所述中药组合物的制备方法包括:
(1)按配方称取原料粉碎后混合;将粉碎后的混合物加水浸泡;浸泡时间为2小时;
(2)浸泡后进行煎煮;第一次加水量为混合物粉料重量的12倍,煎煮1.5小时,第二次加水量为混合物粉料重量的8倍,煎煮1小时;煎煮完成后进行过滤,将滤液进行浓缩,喷雾干燥,制备成颗粒剂即得所述治疗失眠的中药组合物。
实施例2
本实施例用于治疗失眠的中药组合物,由以下重量份原料制成:炙甘草10份、茯苓17份、生姜10份、桂枝7份、酸枣仁12份、龙眼10份、莲子心8份、百合7份、人参12份、竹叶12份、龙骨7份、麦冬11份、白芍16份、当归8份、远志12份、石菖蒲18份、茯神14份。
所述中药组合物的制备方法包括:
(1)按配方称取原料粉碎后混合;将粉碎后的混合物加水浸泡;浸泡时间为2小时;
(2)浸泡后进行煎煮;第一次加水量为混合物粉料重量的12倍,煎煮1.5小时,第二次加水量为混合物粉料重量的8倍,煎煮1小时;煎煮完成后进行过滤,将滤液进行浓缩,喷雾干燥,制备成颗粒剂即得所述治疗失眠的中药组合物。
实施例3
本实施例用于治疗失眠的中药组合物,由以下重量份原料制成:炙甘草12份、茯苓15份、生姜12份、桂枝5份、酸枣仁14份、龙眼8份、莲子心10份、百合5份、人参14份、竹叶10份、龙骨9份、麦冬9份、白芍18份、当归6份、远志14份、石菖蒲16份、茯神16份。
所述中药组合物的制备方法包括:
(1)按配方称取原料粉碎后混合;将粉碎后的混合物加水浸泡;浸泡时间为2小时;
(2)浸泡后进行煎煮;第一次加水量为混合物粉料重量的12倍,煎煮1.5小时,第二次加水量为混合物粉料重量的8倍,煎煮1小时;煎煮完成后进行过滤,将滤液进行浓缩,喷雾干燥,制备成颗粒剂即得所述治疗失眠的中药组合物。
对比例1
本对比例中用于治疗失眠的中药组合物,由以下重量份原料制成:甘草11份、茯苓16份、生姜11份、桂枝6份、酸枣仁13份、龙眼9份、莲子心9份、百合6份、人参13份、竹叶11份、龙骨8份、麦冬10份、白芍17份、当归7份、远志13份、石菖蒲17份、茯神15份。
所述中药组合物的制备方法包括:
(1)按配方称取原料粉碎后混合;将粉碎后的混合物加水浸泡;浸泡时间为2小时;
(2)浸泡后进行煎煮;第一次加水量为混合物粉料重量的12倍,煎煮1.5小时,第二次加水量为混合物粉料重量的8倍,煎煮1小时;煎煮完成后进行过滤,将滤液进行浓缩,喷雾干燥,制备成颗粒剂即得所述治疗失眠的中药组合物。
对比例2
本对比例中用于治疗失眠的中药组合物,由以下重量份原料制成:炙甘草11份、茯苓16份、生姜11份、桂枝6份、大枣13份、龙眼9份、莲子心9份、百合6份、人参13份、竹叶11份、龙骨8份、麦冬10份、白芍17份、当归7份、远志13份、石菖蒲17份、茯神15份。
所述中药组合物的制备方法包括:
(1)按配方称取原料粉碎后混合;将粉碎后的混合物加水浸泡;浸泡时间为2小时;
(2)浸泡后进行煎煮;第一次加水量为混合物粉料重量的12倍,煎煮1.5小时,第二次加水量为混合物粉料重量的8倍,煎煮1小时;煎煮完成后进行过滤,将滤液进行浓缩,喷雾干燥,制备成颗粒剂即得所述治疗失眠的中药组合物。
对比例3
本对比例用于治疗失眠的中药组合物,由以下重量份原料制成:炙甘草11份、茯苓16份、生姜11份、酸枣仁13份、龙眼9份、莲子心9份、百合6份、竹叶11份、龙骨8份、麦冬10份、白芍17份、当归7份、石菖蒲17份、茯神15份。
所述中药组合物的制备方法包括:
(1)按配方称取原料粉碎后混合;将粉碎后的混合物加水浸泡;浸泡时间为2小时;
(2)浸泡后进行煎煮;第一次加水量为混合物粉料重量的12倍,煎煮1.5小时,第二次加水量为混合物粉料重量的8倍,煎煮1小时;煎煮完成后进行过滤,将滤液进行浓缩,喷雾干燥,制备成颗粒剂即得所述治疗失眠的中药组合物。
对比例4
专利CN115252753B公开一种治疗失眠的中药组合物及其应用,具体涉及一种治疗失眠的中药组合物,以质量份计其主要活性成分包括:桂枝10-25份,白芍10-25份,甘草5-25份,生姜10-30份,大枣15-30份,人参10-30份,当归10-30份,巴戟天10-30份,麦冬10-30份。
本对比例中用于治疗失眠的中药组合物,由以下重量份原料制成:桂枝15g,白芍15g,炙甘草15g,生姜20g,大枣20g,生晒参10g,当归15g,巴戟天15g,麦冬10g。
所述中药组合物的制备方法包括:
(1)按配方称取原料粉碎后混合;将粉碎后的混合物加水浸泡;浸泡时间为2小时;
(2)浸泡后进行煎煮;第一次加水量为混合物粉料重量的12倍,煎煮1.5小时,第二次加水量为混合物粉料重量的8倍,煎煮1小时;煎煮完成后进行过滤,将滤液进行浓缩,喷雾干燥,制备成颗粒剂即得所述治疗失眠的中药组合物。
动物药效学实验:
对SD大鼠戊巴比妥钠睡眠时间的影响检测:SD大鼠70只,随机分为7组,即生理盐水对照组,实施例1处方制备的颗粒剂组,对比例1-4处方制备的颗粒剂组;安定阳性对照组,每组10只。其中,SD大鼠为健康SD大鼠,雄性,SPF级,体质量200-220g,购自北京维通利华公司。还需要说明的是,本发明中所需药品均市售可得。
实施例、对比例组:灌胃给药物细粉10.0g/kg,灌胃剂量为5ml/kg,给药体积为0.2ml/10g,灌胃;
安定阳性对照组:给予1mg/kg安定,灌胃;
生理盐水对照组:给予同体积生理盐水,灌胃。
灌胃给药60分钟后,每组SD大鼠分别给予戊巴比妥钠40mg/kg,腹腔注射。记录SD大鼠的睡眠时间(以翻正反射消失为入睡时间,从翻正反射消失至恢复时间为睡眠持续时间)。结果如下表1所示:
表1
注:与生理盐水组相比,*表示P<0.05,**表示P<0.01。
表1中结果显示,本发明中药组合物对SD大鼠的睡眠时间有明显的延长,与生理盐水组比较有显著差异,这一结果证明了本发明药物具有显著的镇静催眠效果,而这一发现对于药物研发和临床应用具有重要意义。此外,还与现有技术中配方进行比较,结果同样显示其性能相较于现有技术依然具备一定优势。
临床疗效实验:
1、选取失眠患者,依据随机数字表法分6组,每组50人;对基本数据进行分析比对,检验结果无差异(P>0.05),具有可比性。(1)纳入标准:①满足《中医内科学》中相关失眠疾病诊断标准者;②满足《中国精神障碍分类与诊断标准》(CCMD-3)中相关失眠疾病诊断标准者;③研究开展前1个月未服用镇静催眠药物治疗者;④了解研究内容,可积极配合研究者。(2)排除标准:①对研究中药物存在过敏、禁忌者;②对伴有内分泌性、感染性疾病者;③伴有严重肝、心、肾疾病者;④近期参与过其他临床研究者。
2、方法:对照组采用西药治疗,每次取10mg酒石酸唑吡坦片(生产企业:鲁南贝特制药有限公司,批准号:H20020372,规格:10片/盒)口服,1次/d,睡前用药。每次取20mg谷维素(生产企业:广东恒健制药有限公司,批准号:H44020613,规格:10mg*100片)口服,2次/d。实验组为实施例1、对比例1-4所使用组方,药材加水煎煮服用,1剂/d,且分早晚两次服用,全部患者均坚持治疗1个月。
3、判断指标:(1)运用匹兹堡睡眠质量指数量表(PSQI)对治疗有效率进行评估:其分值减少百分率区间为76-100%之间定义为痊愈,分值减少百分率区间为51-75%之间定义为显效;分值减少百分率区间为26-50%之间定义为有效;分值减少百分率区间为25%以下定义为无效。(2)评估6组不良反应发生率:心悸、肝功能异常、头痛、胃肠不适等。
4、统计学分析采用SPSS25.0统计学软件进行数据分析,计量资料用表示,6组间比较采用t检验;计数资料用率表示,组间比较采用x2检验,以P<0.05为差异有统计学意义。
对比6组疗效如下表,组间差异显著(P<0.05),详见下表2:
表2
对比6组不良反应发生率(例%)如下表3所示:
表3
根据前述表格对比,本发明中药组合物疗效显著,且不良发生率低,有很好的临床效果,具有实际应用价值。
本具体实施例仅是对本发明的解释,其并不是对本发明的限制,本领域技术人员在阅读完本说明书后可以根据需要对本实施例做出没有创造性贡献的修改,但只要在本发明的权利要求范围内都受到专利法的保护。
Claims (9)
1.一种用于治疗失眠的中药组合物,其特征在于,包括以下重量份原料:炙甘草8-14份、茯苓12-20份、生姜10-12份、桂枝4-8份、酸枣仁10-16份、龙眼8-10份、莲子心6-12份、百合4-8份、人参10-16份、竹叶8-14份、龙骨6-10份、麦冬7-13份、白芍15-20份、当归6-8份、远志12-15份、石菖蒲15-20份、茯神14-16份。
2.根据权利要求1所述的一种用于治疗失眠的中药组合物,其特征在于,包括以下重量份原料:炙甘草10-12份、茯苓15-17份、生姜10-12份、桂枝5-7份、酸枣仁12-14份、龙眼8-10份、莲子心8-10份、百合5-7份、人参12-14份、竹叶10-12份、龙骨7-9份、麦冬9-11份、白芍16-18份、当归6-8份、远志12-14份、石菖蒲16-18份、茯神14-16份。
3.根据权利要求1所述的一种用于治疗失眠的中药组合物,其特征在于,包括以下重量份原料:炙甘草11份、茯苓16份、生姜11份、桂枝6份、酸枣仁13份、龙眼9份、莲子心9份、百合6份、人参13份、竹叶11份、龙骨8份、麦冬10份、白芍17份、当归7份、远志13份、石菖蒲17份、茯神15份。
4.权利要求1-3中任一项所述的用于治疗失眠的中药组合物的制备方法,其特征在于,包括以下步骤:
(1)按配方称取原料粉碎后混合;将粉碎后的混合物加水浸泡;
(2)浸泡后进行煎煮;煎煮完成后进行过滤,将滤液进行浓缩,喷雾干燥,制备成颗粒剂、散剂、胶囊剂、片剂中的一种。
5.根据权利要求4所述的用于治疗失眠的中药组合物的制备方法,其特征在于,所述步骤(1)浸泡时间不少于2小时。
6.根据权利要求4所述的用于治疗失眠的中药组合物的制备方法,其特征在于,所述步骤(2)中煎煮分两次,第一次加水量为混合物粉料重量的10-15倍,第二次加水量为混合物粉料重量的5-10倍,总煎煮时间为2-3小时。
7.权利要求1-3中任一项所述的用于治疗失眠的中药组合物在制备治疗失眠的药物或在制备用于辅助治疗失眠的保健食品中的应用。
8.一种中药制剂,其特征在于,包括权利要求1-3中任一项所述的用于治疗失眠的中药组合物和药学可接受的辅料。
9.根据权利要求8所述的中药制剂,其特征在于,所述中药制剂为颗粒剂、片剂、丸剂、汤剂、散剂、膏剂或胶囊。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202410746172.7A CN118512567A (zh) | 2024-06-11 | 2024-06-11 | 一种用于治疗失眠的中药组合物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202410746172.7A CN118512567A (zh) | 2024-06-11 | 2024-06-11 | 一种用于治疗失眠的中药组合物 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN118512567A true CN118512567A (zh) | 2024-08-20 |
Family
ID=92274064
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202410746172.7A Pending CN118512567A (zh) | 2024-06-11 | 2024-06-11 | 一种用于治疗失眠的中药组合物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN118512567A (zh) |
-
2024
- 2024-06-11 CN CN202410746172.7A patent/CN118512567A/zh active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102078402B (zh) | 治疗高血压、高血脂和高血糖的中药组合物 | |
CN101543248B (zh) | 一种特别适合“三高一酸”人群饮用的凉茶及其制备方法 | |
CN112294924A (zh) | 一种养心安神药物组合物及其制备方法和应用 | |
CN101745087A (zh) | 一种具有解酒防醉作用的组合物及其制备方法 | |
CN103181949A (zh) | 一种镇静安神口服制剂及其制备方法 | |
CN112843174A (zh) | 一种具有补脾养心安神功能的中药组合物及制备方法以及应用 | |
CN115252753B (zh) | 治疗失眠的中药组合物及其应用 | |
CN103417886B (zh) | 一种治疗支气管哮喘的中药组合物及其制备方法 | |
US20030143289A1 (en) | Herbal composition PHY828 and its use | |
CN117599125A (zh) | 一种用于治疗骨质疏松症的补钙壮骨中药组合物及制法和应用 | |
CN112741890B (zh) | 一种治疗眩晕病的中药组合物及其制备方法 | |
CN104547598A (zh) | 一种治疗神经衰弱的中药制剂及制备方法 | |
CN118512567A (zh) | 一种用于治疗失眠的中药组合物 | |
CN103977390A (zh) | 一种生姜洋葱药酒组合物的制备方法及其用途 | |
CN113632979A (zh) | 一种男女通用的四季养生饮料及其制备方法 | |
Kumar et al. | Safety and Toxicity of Botanical Medicines: A critical Appraisal | |
CN117159658B (zh) | 一种预防、减缓或治疗顽固性失眠的中药组合物及制作工艺 | |
CN110201056A (zh) | 一种中药组合物及其制剂、制备方法和应用 | |
CN108553611A (zh) | 一种抗疲劳抗衰老、防治亚健康的天然草本保健茶饮 | |
Singh | Herbal and Natural Medicines for Treatment of Alcoholism and Associated Diseases | |
CN118512524A (zh) | 一种具有抗焦虑降血压作用的中药组合物及其制备方法 | |
CN118320016A (zh) | 一种治疗失眠合并老年夜尿症的药物组合物及制法和应用 | |
CN104606510B (zh) | 用于治疗肿瘤相关性睡眠障碍的铁皮石斛复方制剂 | |
CN116173173A (zh) | 一种治疗抑郁症的中药组合物及制备方法 | |
CN105267815A (zh) | 一种治疗小儿肺肾两虚型哮喘的喷雾剂及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |